The DB Mighty Biosimilar & CDMO Active ETF is an actively managed ETF that seeks capital appreciation by investing in a portfolio comprised primarily of Korean companies involved in the manufacturing of biosimilar products
The DB Mighty Biosimilar & CDMO Active ETF (KRW) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Biotech sector located in South Korea. The DB ASSET fund’s base currency is KRW and the share class was registered 24.12.2024 with unique ISIN - KR70001P0004. Main exchange is Korea Exchange and ticker symbol is 0001P0. The total expense ratio is 0.805%. The DB Mighty Biosimilar & CDMO Active ETF (KRW) pays dividends 1 time(s) per year.